14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
Apr 17, 2020 $48.08 $49.59 $47.09 $49.39 446 860
Apr 16, 2020 $45.51 $47.63 $45.30 $46.84 341 497
Apr 15, 2020 $46.65 $47.86 $45.03 $46.06 350 308
Apr 14, 2020 $47.22 $49.50 $47.22 $48.66 541 009
Apr 13, 2020 $44.93 $46.82 $44.05 $46.38 238 362
Apr 09, 2020 $44.90 $45.50 $43.48 $44.99 566 443
Apr 08, 2020 $43.42 $43.84 $41.77 $43.24 623 659
Apr 07, 2020 $44.94 $45.13 $42.15 $42.60 705 502
Apr 06, 2020 $40.66 $44.26 $39.36 $43.50 631 108
Apr 03, 2020 $39.55 $40.01 $38.25 $38.96 319 136
Apr 02, 2020 $38.39 $40.22 $37.42 $39.75 512 913
Apr 01, 2020 $38.88 $40.24 $38.01 $38.58 495 926
Mar 31, 2020 $39.70 $40.87 $38.24 $40.18 551 826
Mar 30, 2020 $38.86 $39.92 $37.13 $39.60 924 374
Mar 27, 2020 $38.13 $40.18 $38.00 $38.55 585 782
Mar 26, 2020 $38.90 $41.72 $38.38 $39.91 548 498
Mar 25, 2020 $39.08 $40.78 $37.35 $38.86 718 862
Mar 24, 2020 $40.00 $41.46 $37.31 $39.28 737 561
Mar 23, 2020 $37.02 $39.00 $33.87 $37.55 577 975
Mar 20, 2020 $35.94 $38.78 $35.20 $36.83 873 089
Mar 19, 2020 $32.54 $36.33 $31.77 $34.97 767 512
Mar 18, 2020 $33.73 $35.82 $30.72 $32.73 1 172 031
Mar 17, 2020 $35.32 $36.00 $31.66 $35.05 1 167 006
Mar 16, 2020 $36.39 $41.26 $33.03 $34.43 1 177 128
Mar 13, 2020 $41.36 $44.44 $37.55 $44.44 1 187 483
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT